DPW
IBRX icon

DiNuzzo Private Wealth’s ImmunityBio IBRX Stock Holding History

DiNuzzo Private Wealth’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$316 Buy
+36
New +$272 ﹤0.01% 1197
2026
Q1 		– Sell
-3
Closed -$6 – 1368
2025
Q4 		$6 Hold
3
– – ﹤0.01% 1367
2025
Q3 		$8 Sell
3
-7
-70% -$18 ﹤0.01% 1369
2025
Q2 		$27 Hold
10
– – ﹤0.01% 1351
2025
Q1 		$31 Sell
10
-52
-84% -$158 ﹤0.01% 1350
2024
Q4 		$159 Buy
62
+45
+265% +$187 ﹤0.01% 1299
2024
Q3 		$64 Sell
17
-34
-67% -$157 ﹤0.01% 1391
2024
Q2 		$323 Buy
51
+48
+1,600% +$316 ﹤0.01% 1167
2024
Q1 		$17 Buy
+3
New +$14 ﹤0.01% 1355

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DiNuzzo Private Wealth's IBRX Position: Q2 2026 in Review

DiNuzzo Private Wealth opened a new position in ImmunityBio (IBRX) in Q2 2026: 36 shares worth $316. The stake represents ﹤0.01% of the portfolio and ranks #1197 among its holdings. This is a return to the name: DiNuzzo Private Wealth previously reported a position in IBRX as recently as Q4 2025.

DiNuzzo Private Wealth first reported a position in IBRX in Q1 2024 and has held it in 9 quarters since. The position peaked at $323 in Q2 2024. 404 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • DiNuzzo Private Wealth held 36 shares of ImmunityBio worth $316 as of Q2 2026.
  • ImmunityBio was a new DiNuzzo Private Wealth position in Q2 2026.
  • ImmunityBio made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #1197 holding.
  • DiNuzzo Private Wealth first reported a position in ImmunityBio in Q1 2024 and has held it in 9 quarters since.
  • DiNuzzo Private Wealth's ImmunityBio position peaked at $323 in Q2 2024.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.